Related references
Note: Only part of the references are listed.5-HT7R/G12 Signaling Regulates Neuronal Morphology and Function in an Age-Dependent Manner
Fritz Kobe et al.
JOURNAL OF NEUROSCIENCE (2012)
Spinal 5-HT7 Receptors Play an Important Role in the Antinociceptive and Antihyperalgesic Effects of Tramadol and Its Metabolite, O-Desmethyltramadol, via Activation of Descending Serotonergic Pathways
Omer Yanarates et al.
ANESTHESIOLOGY (2010)
Selective Inhibition of 5-HT7 Receptor Reduces CGRP Release in an Experimental Model for Migraine
Xiaojuan Wang et al.
HEADACHE (2010)
Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation
A. P. Andreou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice
Alex Brenchat et al.
PAIN (2009)
Headache and multiple sclerosis: a population-based case-control study in Catania, Sicily
A. Nicoletti et al.
CEPHALALGIA (2008)
Toward an epidemiology of refractory migraine: Current knowledge and issues for future research
Richard B. Lipton et al.
HEADACHE (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
The calcitonin gene-related peptide (CGR-P) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow
Markus Troeltzsch et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The role of 5-HT7 receptors in the control of seizures
Danka Pericic et al.
BRAIN RESEARCH (2007)
5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats
Jose A. Terron et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression
Anna Wesolowska et al.
NEUROPHARMACOLOGY (2006)
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
PB Hedlund et al.
BIOLOGICAL PSYCHIATRY (2005)
Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells
C Mahé et al.
NEUROPHARMACOLOGY (2005)
Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy
M Graf et al.
NEUROSCIENCE LETTERS (2004)
Functional, molecular and pharmacological advances in 5-HT7 receptor research
PB Hedlund et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat
RJ Storer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Autoradiographic distribution of 5-HT7 receptors in the human brain using [H-3]mesulergine: comparison to other mammalian species
FJ Martin-Cora et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Mechanisms of action of the 5-HT1B/1D receptor agonists
SJ Tepper et al.
ARCHIVES OF NEUROLOGY (2002)
Molecular, pharmacological and functional diversity of 5-HT receptors
D Hoyer et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Drug therapy: Migraine - Current understanding and treatment.
PJ Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:: a meta-analysis of 53 trials
MD Ferrari et al.
LANCET (2001)
The anti-migraine 5-HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs
DJ Williamson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
The effect of adrenergic compounds on neurogenic dural vasodilatation
S Akerman et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats
DJ Williamson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
5-HT7 receptor mRNA expression in human trigeminal ganglia
JA Terrón et al.
NEUROSCIENCE LETTERS (2001)
Share Paper
